Hair Loss Treatment Targets Dormant Follicle Stem Cells [Clinical Trial]
MedEsthetics
AUGUST 21, 2024
Pelage Pharmaceuticals announced the commencement of the Phase 2a trial for PP405, a novel hair loss treatment targeting dormant follicle stem cells.
Let's personalize your content